Bill H Chang Selected Research

MicroRNAs (MicroRNA)

6/2015

Serum Exosome MicroRNA as a Minimally-Invasive Early Biomarker of AML.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bill H Chang Research Topics

Disease

12	Neoplasms (Cancer) 11/2023 - 05/2009
11	Leukemia 01/2024 - 01/2013
11	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2021 - 09/2012
8	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2024 - 06/2015
4	Lymphoma (Lymphomas) 01/2024 - 08/2016
4	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2017 - 05/2013
2	Philadelphia Chromosome 01/2021 - 01/2018
1	T-Cell Leukemia (Leukemia, T Cell) 10/2023
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2020
1	Juvenile Myelomonocytic Leukemia 01/2018
1	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (Leukemia, Pre B Cell) 01/2018
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 09/2017
1	Hodgkin Disease (Hodgkin's Disease) 09/2017
1	Hyperbilirubinemia 08/2016
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2016
1	Hematologic Neoplasms (Hematological Malignancy) 01/2016
1	Bacteremia 07/2015
1	Fever (Fevers) 07/2015
1	Infections 07/2015
1	Neutropenia 07/2015
1	Residual Neoplasm 06/2015
1	Paraneoplastic Syndromes (Paraneoplastic Syndrome) 09/2006
1	Neuroblastoma 09/2006
1	Opsoclonus-Myoclonus Syndrome (Kinsbourne Syndrome) 09/2006

Drug/Important Bio-Agent (IBA)

5	venetoclaxIBA 11/2023 - 01/2016
5	Phosphotransferases (Kinase)IBA 01/2020 - 01/2013
4	Dasatinib (BMS 354825)FDA Link 01/2018 - 09/2012
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2016 - 05/2013
2	Azacitidine (5 Azacytidine)FDA Link 01/2024 - 11/2023
2	Decitabine FDA Link 01/2022 - 01/2020
2	Vorinostat FDA Link 01/2022 - 01/2020
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 05/2013
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 12/2016 - 08/2016
2	Pre-B Cell ReceptorsIBA 03/2015 - 11/2012
1	NivolumabIBA 01/2024
1	AntibodiesIBA 10/2023
1	Mitogen-Activated Protein Kinase 14IBA 01/2022
1	doramapimodIBA 01/2022
1	p38 Mitogen-Activated Protein KinasesIBA 01/2022
1	Aurora Kinase AIBA 11/2021
1	blinatumomabIBA 01/2021
1	ibrutinibIBA 01/2020
1	Small Interfering RNA (siRNA)IBA 01/2018
1	Protein Tyrosine PhosphatasesIBA 01/2018
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2018
1	Imatinib Mesylate (Gleevec)FDA Link 01/2018
1	Monoclonal AntibodiesIBA 09/2017
1	DNA (Deoxyribonucleic Acid)IBA 01/2017
1	tirbanibulinIBA 01/2017
1	Bromodeoxyuridine (BrdU)IBA 01/2017
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	Serine (L-Serine)FDA Link 12/2016
1	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 12/2016
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 12/2016
1	Threonine (L-Threonine)FDA Link 12/2016
1	4- amino- 5- fluoro- 3- (5- (4- methylpiperazin- 1- yl)- 1H- benzimidazol- 2- yl)quinolin- 2(1H)- oneIBA 12/2016
1	Tyrosine (L-Tyrosine)FDA Link 12/2016
1	Oncogene Proteins (Oncogene Protein)IBA 12/2016
1	quizartinibIBA 08/2016
1	Lipase (Acid Lipase)FDA Link 08/2016
1	ponatinibIBA 01/2016
1	Bcl-2-Like Protein 11IBA 01/2016
1	CoagulaseIBA 07/2015
1	Anti-Bacterial Agents (Antibiotics)IBA 07/2015
1	MicroRNAs (MicroRNA)IBA 06/2015
1	preemptIBA 06/2015
1	Anaplastic Lymphoma KinaseIBA 06/2015
1	SurvivinIBA 04/2015
1	sepantroniumIBA 04/2015
1	InterleukinsIBA 05/2013
1	Tumor Biomarkers (Tumor Markers)IBA 10/2012
1	AutoantigensIBA 09/2006
1	Rituximab (Mabthera)FDA Link 09/2006

Therapy/Procedure

11	Therapeutics 11/2023 - 09/2006
4	Drug Therapy (Chemotherapy) 01/2022 - 08/2016
1	Cranial Irradiation 01/2018
1	Investigational Therapies (Experimental Therapy) 09/2017
1	Molecular Targeted Therapy 05/2013